article

1. Cardiac adverse events after Chimeric Antigen Receptor (CAR) T cell therapies: an updated systematic review and meta-analysis..  Cardio-oncology (London, England).  10:-. 2024
2. Comparative Analysis of PCI Strategies in Aortic Stenosis Patients Undergoing TAVI: A Systematic Review and Network Meta-Analysis..  Clinical cardiology.  47:-. 2024
3. Searching for Meaning: Refining Troponin Thresholds to Align Risks Between Spontaneous and Procedural Myocardial Infarction..  Journal of the American College of Cardiology.  84:478-481. 2024
4. Frailty and Cardiovascular Health..  Journal of the American Heart Association.  13:-. 2024
5. Risk of Atherosclerotic Cardiovascular Disease Hospitalizations after COPD Hospitalization among Older Adults..  Annals of the American Thoracic Society.  2024
6. Percutaneous Coronary Revascularization Strategies After Myocardial Infarction: A Systematic Review and Network Meta-Analysis..  Journal of the American College of Cardiology.  84:276-294. 2024
7. Trend of Controlled Low-Density Lipoprotein Cholesterol in Older Adults With a History of Myocardial Infarction or Stroke..  JACC. Advances.  3:-. 2024
8. Representation of Older Adults in the ACC/AHA/SCAI Guideline for Coronary Artery Revascularization..  JAMA network open.  7:-. 2024
9. Frailty in the Cardiac Intensive Care Unit: Assessment and Impact..  European heart journal. Acute cardiovascular care.  13:506-514. 2024
10. Apixaban to Prevent Recurrence After Cryptogenic Stroke..  JAMA.  331:1965-1966. 2024
11. Apixaban to Prevent Recurrence After Cryptogenic Stroke..  JAMA.  331:1965-1966. 2024
12. Quality of Life in Older Adults With Stable Ischemic Heart Disease and Diabetes Mellitus: A Post Hoc Analysis of the BARI 2D Trial..  The American journal of cardiology.  58-69. 2024
13. Case Volumes and Outcomes Among Early-Career Interventional Cardiologists in the United States..  Journal of the American College of Cardiology.  83:1990-1998. 2024
14. Machine learning prediction of one-year mortality after percutaneous coronary intervention in acute coronary syndrome patients..  International journal of cardiology.  -. 2024
15. Association Between Frailty and Management and Outcomes of Acute Myocardial Infarction Complicated by Cardiogenic Shock..  JACC. Advances.  3:-. 2024
16. Seasonal variations in admissions for atrial fibrillation or atrial flutter in the Northeast and the Midwest regions of the United States..  Proceedings (Baylor University. Medical Center).  37:560-568. 2024
17. Chronological vs Biological Age in Interventional Cardiology: A Comprehensive Approach to Care for Older Adults: JACC Family Series..  JACC. Cardiovascular interventions.  17:961-978. 2024
18. Frailty and In-Hospital Outcomes for Management of Cardiogenic Shock without Acute Myocardial Infarction..  Journal of clinical medicine.  13. 2024
19. Association of cardiovascular diseases with cognitive performance in older adults..  American heart journal.  10-20. 2024
20. Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis..  Journal of the Society for Cardiovascular Angiography & Interventions.  3:-. 2024
21. Shorter Dual Antiplatelet Therapy for Older Adults After Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis..  JAMA network open.  7:-. 2024
22. Role of Cognitive Frailty in Older Adults With Cardiovascular Disease..  Journal of the American Heart Association.  13:-. 2024
23. Intravascular Imaging-Guided Versus Angiography-Guided Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Trials..  Journal of the American Heart Association.  13:-. 2024
24. Chronic Coronary Disease in Older Adults..  The Medical clinics of North America.  108:581-594. 2024
25. Risk Prediction for Atherosclerotic Cardiovascular Disease With and Without Race Stratification..  JAMA cardiology.  9:55-62. 2024
26. Do Clinical Outcomes and Quality of Life Differ by the Number of Antianginals for Stable Ischemic Heart Disease? Insights from the BARI 2D Trial..  The American journal of cardiology.  66-76. 2023
27. The association of timing of coronary artery bypass grafting for non-ST-elevation myocardial infarction and clinical outcomes in the contemporary United States..  Coronary artery disease.  35:261-269. 2023
28. Risk of Atherosclerotic Cardiovascular Disease Hospitalizations after COPD Hospitalization among Older Adults..  medRxiv : the preprint server for health sciences.  2023
29. The Brain-Heart Axis: Neuroinflammatory Interactions in Cardiovascular Disease..  Current cardiology reports.  25:1745-1758. 2023
30. Beyond MACE: a multidimensional approach to outcomes in clinical trials for older adults with stable ischemic heart disease..  Frontiers in cardiovascular medicine.  -. 2023
31. Clinical and Hemodynamic Outcomes of Balloon-Expandable Mitral Valve-in-Valve Positioning and Asymmetric Deployment: The VIVID Registry..  JACC. Cardiovascular interventions.  16:2615-2627. 2023
32. Comparative Analysis of Mortality and Amputation Rates in Patients Undergoing Atherectomy for Infra-Popliteal Peripheral Arterial Disease: Insight From the VQI..  Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.  -. 2023
33. Comparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients With Suspected Coronary Artery Disease: The PRECISE Randomized Clinical Trial..  JAMA cardiology.  8:904-914. 2023
34. Deferred Testing in Stable Outpatients With Suspected Coronary Artery Disease: A Prespecified Secondary Analysis of the PRECISE Randomized Clinical Trial..  JAMA cardiology.  8:915-924. 2023
35. Complex Percutaneous Coronary Intervention Outcomes in Older Adults..  Journal of the American Heart Association.  12:-. 2023
36. Insight Into the Optimal Timing of Percutaneous Coronary Intervention and Transcatheter Aortic Valve Replacement..  Current problems in cardiology.  49:-. 2023
37. Life's Essential 8: Optimizing Health in Older Adults..  JACC. Advances.  2. 2023
38. Obesity and Undernutrition in Acute Myocardial Infarction..  The American journal of cardiology.  529-530. 2023
39. JACC: Advances.  JACC. Advances.  2. 2023
40. Comparison of intravascular ultrasound, optical coherence tomography, and conventional angiography-guided percutaneous coronary interventions: A systematic review, network meta-analysis, and meta-regression..  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.  102:440-450. 2023
41. Chronic kidney disease and aortic valve replacement: Let's filter the evidence!.  Trends in cardiovascular medicine.  34:325-326. 2023
42. Delirium in older adults after percutaneous coronary intervention: Prevalence, risks, and clinical phenotypes..  Cardiovascular revascularization medicine : including molecular interventions.  60-67. 2023
43. JACC: Advances.  JACC. Advances.  2. 2023
44. Hierarchical Development of Physical Frailty and Cognitive Impairment and Their Association With Incident Cardiovascular Disease..  JACC. Advances.  2. 2023
45. Stable Coronary Artery Disease in the Age of Geriatric Cardiology..  Journal of the American College of Cardiology.  81:1710-1713. 2023
46. Carcinoid Heart Disease-Induced Right-Sided Heart Failure as a Culprit for Significant Ascites..  Case reports in gastroenterology.  17:172-177. 2023
47. Management of Stable Angina in the Older Adult Population..  Circulation. Cardiovascular interventions.  16:-. 2023
48. Doing Harm by Doing No Harm? Resisting the Urge to Retire GDMT in Older Adults With Heart Failure..  Journal of cardiac failure.  29:445-447. 2023
49. Clinical and Cost Implications of Deferred Testing in Low-risk Patients with Stable Chest Pain: A Simulation Using the PROMISE Trial..  American heart journal.  124-126. 2023
50. Trends and impact of intravascular ultrasound and optical coherence tomography on percutaneous coronary intervention for myocardial infarction..  International journal of cardiology. Heart & vasculature.  -. 2023
51. The Heterogeneity of Old Age: Healthy Aging in Older Adults Undergoing TAVR..  JACC. Cardiovascular interventions.  16:189-192. 2023
52. Contemporary Weekend Effect on Management and In-Hospital Outcomes of Non-ST Elevation Myocardial Infarction..  Cardiovascular revascularization medicine : including molecular interventions.  61-62. 2023
53. Use of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagonlike Peptide-1 Receptor Agonists in Patients With Diabetes and Cardiovascular Disease in Community Practice..  JAMA cardiology.  8:89-95. 2023
54. Lipid-lowering treatment among older patients with atherosclerotic cardiovascular disease..  Journal of the American Geriatrics Society.  71:1243-1249. 2022
55. Network Meta-Analysis Comparing Angiotensin Receptor-Neprilysin Inhibitors, Angiotensin Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors in Heart Failure With Reduced Ejection Fraction..  The American journal of cardiology.  84-92. 2022
56. Readmission and adverse outcomes after percutaneous coronary intervention in patients with dementia..  Journal of the American Geriatrics Society.  71:1034-1046. 2022
57. Deprescription of aspirin for primary prevention is uncommon at discharge in hospitalised patients with gastrointestinal bleeding..  Alimentary pharmacology & therapeutics.  57:94-102. 2022
58. Primary prevention statin therapy in older adults..  Current opinion in cardiology.  38:11-20. 2022
59. Readmission rates and risk factors for readmission after transcatheter aortic valve replacement in patients with end-stage renal disease..  PloS one.  17:-. 2022
60. In-hospital outcomes and readmission in older adults treated with percutaneous coronary intervention for stable ischemic heart disease..  Journal of geriatric cardiology : JGC.  19:631-642. 2022
61. Readmission and In-Hospital Outcomes After Transcatheter Aortic Valve Replacement in Patients With Dementia..  Cardiovascular revascularization medicine : including molecular interventions.  70-77. 2022
62. Choice of Antihypertensive Agent in Isolated Systolic Hypertension and Isolated Diastolic Hypertension: A Secondary Analysis of the ALLHAT Trial..  American heart journal.  30-34. 2022
63. Cost-effectiveness of Pulmonary Rehabilitation Among US Adults With Chronic Obstructive Pulmonary Disease..  JAMA network open.  5:-. 2022
64. Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis..  American heart journal.  101-114. 2022
65. An age-old dilemma: Defining the optimal revascularization approach in older adults..  Journal of the American Geriatrics Society.  70:2205-2208. 2022
66. High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S..  Journal of the American College of Cardiology.  79:1802-1813. 2022
67. Are risk factors necessary for pretest probability assessment of coronary artery disease? A patient similarity network analysis of the PROMISE trial..  Journal of cardiovascular computed tomography.  16:397-403. 2022
68. The prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization: Rationale and design of the PRECISE trial..  American heart journal.  136-148. 2021
69. Moving the Field Forward: Untangling the Impact of Frailty on Patients With Advanced Heart Failure and on Prognosticating Outcomes..  Journal of cardiac failure.  28:775-777. 2021
70. Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the Week..  Journal of the American College of Cardiology.  78:1550-1563. 2021
71. Rise of the Machines: Where Virtual Processing Meets Percutaneous Coronary Intervention..  The Canadian journal of cardiology.  37:1504-1506. 2021
72. Precision medicine gets an ASSIST in diagnostic testing..  European heart journal.  42:2549-2551. 2021
73. The incremental value of angiographic features for predicting recurrent cardiovascular events: Insights from the Duke Databank for Cardiovascular Disease..  Atherosclerosis.  1-7. 2021
74. Cholesterol Lowering and Coronary Revascularization: Finally a Marriage to Sustain?.  Journal of the American College of Cardiology.  77:268-270. 2021
75. 180-day readmission risk model for older adults with acute myocardial infarction: the SILVER-AMI study..  Open heart.  8. 2021
76. The Cumulative Impact of Chronic Stressors on Risks of Myocardial Infarction in US Older Adults..  Psychosomatic medicine.  83:987-994. 2021
77. Can the Absence of Hypertension Refine the Risk Assessment of Older Adults for Future Cardiovascular Events?.  The American journal of cardiology.  83-90. 2020
78. Representation of Older Adults in Cardiovascular Disease Trials Since the Inclusion Across the Lifespan Policy..  JAMA internal medicine.  180:1531-1533. 2020
79. Presentation, Treatment, and Outcomes of the Oldest-Old Patients with Acute Myocardial Infarction: The SILVER-AMI Study..  The American journal of medicine.  134:95-103. 2020
80. Teaching Old Treatments New Tricks..  Circulation. Cardiovascular interventions.  13:-. 2020
81. Prevalence, treatment, and control of severe hyperlipidemia..  American journal of preventive cardiology.  -. 2020
82. Performance of Guideline Recommendations for Prevention of Myocardial Infarction in Young Adults..  Journal of the American College of Cardiology.  76:653-664. 2020
83. Racial Differences in Long-Term Cardiovascular Outcomes: The Need to Move From Description to Action..  JACC. Cardiovascular interventions.  13:1596-1598. 2020
84. Weight change in heart failure inpatients not associated with 30-day readmission..  Future cardiology.  16:289-296. 2020
85. Age-Related Differences in the Noninvasive Evaluation for Possible Coronary Artery Disease: Insights From the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) Trial..  JAMA cardiology.  5:193-201. 2020
86. Translating the Secondary Prevention Therapeutic Boom Into Action..  JAMA cardiology.  5:215-216. 2020
87. Predicting 6-Month Mortality for Older Adults Hospitalized With Acute Myocardial Infarction: A Cohort Study..  Annals of internal medicine.  172:12-21. 2019
88. A systematic review of randomized trials comparing double versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention..  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.  96:E102-E109. 2019
89. The Accuracy of Cardiovascular Pooled Cohort Risk Estimates in U.S. Older Adults..  Journal of general internal medicine.  35:1701-1708. 2019
90. Sex-Based Differences in Presentation, Treatment, and Complications Among Older Adults Hospitalized for Acute Myocardial Infarction: The SILVER-AMI Study..  Circulation. Cardiovascular quality and outcomes.  12:-. 2019
91. Sex Differences in the Use of Statins in Community Practice..  Circulation. Cardiovascular quality and outcomes.  12:-. 2019
92. The Association Between Low-Density Lipoprotein Cholesterol and Incident Atherosclerotic Cardiovascular Disease in Older Adults: Results From the National Institutes of Health Pooled Cohorts..  Journal of the American Geriatrics Society.  67:2560-2567. 2019
93. Highlights From the American Heart Association's EPI|LIFESTYLE 2019 Scientific Sessions..  Journal of the American Heart Association.  8:-. 2019
94. Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry..  American heart journal.  113-124. 2019
95. Thirty-Day Readmission Risk Model for Older Adults Hospitalized With Acute Myocardial Infarction..  Circulation. Cardiovascular quality and outcomes.  12:-. 2019
96. Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry..  JAMA cardiology.  3:739-748. 2018
97. Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry..  Journal of the American Heart Association.  7. 2018
98. Long-Term Cognitive Decline After Newly Diagnosed Heart Failure: Longitudinal Analysis in the CHS (Cardiovascular Health Study)..  Circulation. Heart failure.  11:-. 2018
99. Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry..  Circulation. Cardiovascular quality and outcomes.  11:-. 2018
100. Benefits and risks of P2Y12 inhibitor preloading in patients with acute coronary syndrome and stable angina..  Journal of thrombosis and thrombolysis.  44:303-315. 2017
101. Carotid artery stenting versus carotid endarterectomy..  Postgraduate medical journal.  92:532-9. 2016
102. Emergent pacemaker placement in a patient with Lyme carditis-induced complete heart block and ventricular asystole..  BMJ case reports.  2016
103. Physicians' perceptions of the Thrombolysis in Myocardial Infarction (TIMI) risk score in older adults with acute myocardial infarction..  Heart & lung : the journal of critical care.  44:376-81. 2015
104. Risk Stratification in Older Patients With Acute Myocardial Infarction: Physicians' Perspectives..  Journal of aging and health.  28:387-402. 2015
105. Pregnancy complicated by valvular heart disease: an update..  Journal of the American Heart Association.  3:-. 2014